Search research articles
Contact Us
Filters
Showing results (61-70 of 205) with videos related to
Page
of 21
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 20, 2018
Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer
Xinyi Wang, Haiyang Zhang, Ming Bai, et al.
Signal Transduction and Targeted Therapy
|
May 11, 2026
The evolving global landscape of first-in-class oncology drug innovation
Xiangyun Mao, Zhaoqing Wang, Shu Kong, et al.
Cancer Biology & Medicine
|
December 26, 2023
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
Ming Bai, Yao Lu, Chunmei Shi, et al.
EMBO Reports
|
November 15, 2021
lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin
Xinyi Wang, Haiyang Zhang, Shengjie Yin, et al.
Cancer
|
August 17, 2025
Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial
Ming Bai, Yao Lu, Lin Shen, et al.
Cell Death & Disease
|
September 10, 2024
A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCC
Zhengyang Zhou, Hongdian Zhang, Jian Du, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2024
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study
Ting Deng, Feixue Wang, Le Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 29, 2017
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Qian Fan, Xiuting Hu, Haiyang Zhang, et al.
Oncotarget
|
June 16, 2016
Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer
Jingjing Duan, Haiyang Zhang, Yanjun Qu, et al.
Therapeutic Advances in Medical Oncology
|
August 2, 2023
Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study
Ting Deng, Zhigang Liu, Zhengquan Han, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 205) with videos related to
Sort By:
Page
of 21
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 20, 2018
Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer
Xinyi Wang, Haiyang Zhang, Ming Bai, et al.
Signal Transduction and Targeted Therapy
|
May 11, 2026
The evolving global landscape of first-in-class oncology drug innovation
Xiangyun Mao, Zhaoqing Wang, Shu Kong, et al.
Cancer Biology & Medicine
|
December 26, 2023
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
Ming Bai, Yao Lu, Chunmei Shi, et al.
EMBO Reports
|
November 15, 2021
lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin
Xinyi Wang, Haiyang Zhang, Shengjie Yin, et al.
Cancer
|
August 17, 2025
Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial
Ming Bai, Yao Lu, Lin Shen, et al.
Cell Death & Disease
|
September 10, 2024
A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCC
Zhengyang Zhou, Hongdian Zhang, Jian Du, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2024
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study
Ting Deng, Feixue Wang, Le Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 29, 2017
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Qian Fan, Xiuting Hu, Haiyang Zhang, et al.
Oncotarget
|
June 16, 2016
Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer
Jingjing Duan, Haiyang Zhang, Yanjun Qu, et al.
Therapeutic Advances in Medical Oncology
|
August 2, 2023
Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study
Ting Deng, Zhigang Liu, Zhengquan Han, et al.
Page
of 21